InvestorsHub Logo
Followers 47
Posts 6425
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Monday, 11/02/2020 12:43:17 PM

Monday, November 02, 2020 12:43:17 PM

Post# of 474044
News on Biogen (sorry if posted previousl):

UPDATED: Biogen dodges a bullet in its controversial quest to gain an approval for their experimental Alzheimer’s drug aducanumab


https://endpts.com/biogen-misses-a-bullet-in-its-controversial-quest-to-gain-an-approval-for-their-experimental-alzheimers-drug-aducanumab/

Plus, Paul Aisen is IN Biogen's corner per the article.

Per John Carroll:

We’ll know more on Wednesday when the FDA will release its in-house review. And the panel review comes on Friday.




ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News